Syneos Health Leaders Recognized as 2026 PM360 ELITE 100 Award Recipients

Honored for Innovation and Impact Across the Biopharmaceutical Industry

MORRISVILLE, N.C. - Syneos Health^®, a leading fully integrated biopharmaceutical solutions organization, today announced that three of its distinguished colleagues have been named to the 2026 PM360 ELITE 100. This annual recognition honors the most influential leaders and innovators across the healthcare and life sciences industries.

"This recognition reflects the strength of our people and the impact they deliver for customers - from development through launch and beyond," said Costa Panagos, CEO, Syneos Health. "Diana, Paul and Pauline represent how we work at our best - navigating complexity and anticipating what's next. By combining deep expertise, global scale and technology-led execution, we help customers move programs forward with confidence."

• Diana Cucos, President, FSP 360, Syneos Health - Disrupters
  Diana is redefining how biopharmaceutical companies approach outsourcing, transforming the Functional Service Provider (FSP) model into a strategic operating framework rather than a transactional solution. She has built a globally integrated organization that emphasizes strong governance, embedded expertise, and long-term partnership, enabling teams to navigate complexity and deliver at scale.
• Paul Iazzetti, Director, Product Management, Advanced AI Systems, Syneos Health - Tech-Know Geeks
  Paul is at the forefront of applying advanced artificial intelligence (AI) to some of the life sciences industry's most complex challenges. He has led the development of agentic AI tools that are reshaping how organizations operate. As a key contributor to Syneos Health's Digital Amplifier, his work has improved clinical trial site selection, strengthened enrollment forecasting and enhanced healthcare professional engagement strategies.
• Pauline Ng, Executive Vice President, Cadent Medical Communications, Syneos Health Communications - Transformational Leaders
  Pauline is evolving the role of Medical Affairs within healthcare communications, repositioning a publications-focused capability into a strategic, integrated offering spanning evidence generation, medical strategy and field support. The organization has strengthened its position as a trusted partner to clients, expanding strategic engagements and advancing more connected, insight-driven approaches to scientific communications.

These recognitions reinforce Syneos Health's Driven to Deliver purpose - turning opportunity into outcomes for customers, colleagues and most importantly those in need.

About Syneos Health

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, commercial and real world insights into outcomes to address modern market realities.

We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share diverse insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients.

Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment.

Learn more about how our expert team members can help accelerate your success. Visit syneoshealth.com.